{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Feasibility and Randomized Phase 2\/3 Study of the VEFGR2\/MET Inhibitor Cabozantinib in Combination With Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma","item":"https:\/\/www.regionalcancercare.org\/trials\/a-feasibility-and-randomized-phase-2-3-study-of-the-vefgr2-met-inhibitor-cabozantinib-in-combination-with-cytotoxic-chemotherapy-for-newly-diagnosed-osteosarcoma\/#breadcrumbitem"}]}